Stay updated on XEN1101 vs Placebo in Focal-Onset Seizures Clinical Trial
Sign up to get notified when there's something new on the XEN1101 vs Placebo in Focal-Onset Seizures Clinical Trial page.
Latest updates to the XEN1101 vs Placebo in Focal-Onset Seizures Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2; there are no visible changes to page content or layout.SummaryDifference0.0%
- Check28 days agoChange DetectedRemoval of a generic government funding status notice occurred; core study details (title, NCT number, locations, eligibility criteria, and outcomes) remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%
- Check35 days agoChange DetectedThe 'Last Update Posted' field has been replaced with 'Last Update Posted (Estimated)', introducing an estimated timestamp for the last update.SummaryDifference0.0%
- Check42 days agoChange DetectedDifference1%
- Check56 days agoChange DetectedMajor updates to study recruitment locations and status; total locations increased from 67 to 69, new locations added internationally, and status/timeframe fields updated (Withdrawn, Last Update Posted (Estimated)).SummaryDifference2%
- Check71 days agoChange DetectedMajor update: announces a version upgrade to v3.2.0 and publicly states funding-related operational notices, including that transactions may not be processed until appropriations are enacted.SummaryDifference4%
Stay in the know with updates to XEN1101 vs Placebo in Focal-Onset Seizures Clinical Trial
Enter your email address, and we'll notify you when there's something new on the XEN1101 vs Placebo in Focal-Onset Seizures Clinical Trial page.